Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Migraine (prevention) (Botulinum toxin type A - Migraine (prevention))

Records returned : 19 (on 29 May 2025 at 11:34:00). Return to search results for ' Migraine (prevention) '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Botulinum toxin type A

Drug:

Botulinum toxin type A

Indication :

Migraine (prevention)

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Important

For Chronic migraine only.

RSFT: Neurology only
SASH: Botox only Neurology Only

Neurology teams only. NOTE; different brands of botulinum toxin have difference licenses, please check SmPC

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

2. Amitriptyline hydrochloride

Drug:

Amitriptyline hydrochloride

Indication :

Migraine (prevention)

Status :

Green

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

3. Candesartan cilexetil

Drug:

Candesartan cilexetil

Indication :

Migraine (prevention)

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Off-label use

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

4. Propranolol hydrochloride

Drug:

Propranolol hydrochloride

Indication :

Migraine (prevention)

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

5. Topiramate

Drug:

Topiramate

Indication :

Migraine (prevention)

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Pregnancy Prevention Plan required for females of childbearing potential.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

7. Topiramate

Drug:

Topiramate

Indication :

Migraine (prevention)

Status :

Green (see narrative)

Formulations :

Capsules

Restrictions / Comments:

Important

Pregnancy Prevention Plan required for females of childbearing potential.

Capsules (Sprinkle) reserved for use in patients who cannot swallow tablets.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

8. Topiramate

Drug:

Topiramate

Indication :

Migraine (prevention)

Status :

Green (see narrative)

Formulations :

Oral suspension

Restrictions / Comments:

Important

Pregnancy Prevention Plan required for females of childbearing potential.

Only use where patient cannot swallow tablets or capsules (sprinkle) are not suitable.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

6. Pizotifen

Drug:

Pizotifen

Indication :

Migraine (prevention)

Status :

Green (see narrative)

Formulations :

Tablets

Restrictions / Comments:

Important

Review existing patients and consider alternative. Discontinuation of pizotifen requires gradual withdrawal.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

Drug:

Indication :

Migraine (prevention)

Status :

Amber

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

10. Atogepant

Drug:

Atogepant

Indication :

Migraine (prevention)

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

ICB

NICE

11. Eptinezumab

Drug:

Eptinezumab

Indication :

Migraine (prevention)

Status :

Red

Formulations :

Intravenous infusion

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NICE

12. Erenumab

Drug:

Erenumab

Indication :

Migraine (prevention)

Status :

Red

Formulations :

Subcutaneous injection (sc)

Restrictions / Comments:

Preferred

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

ICB

NICE

13. Flunarizine dihydrochloride

Drug:

Flunarizine dihydrochloride

Indication :

Migraine (prevention)

Status :

Red

Formulations :

Not Specified

Restrictions / Comments:

Important

Restricted to use in patients who are intolerant or refractory to other treatment options

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

14. Fremanezumab

Drug:

Fremanezumab

Indication :

Migraine (prevention)

Status :

Red

Formulations :

Subcutaneous injection (sc)

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

ICB

NICE

15. Galcanezumab

Drug:

Galcanezumab

Indication :

Migraine (prevention)

Status :

Red

Formulations :

Subcutaneous injection (sc)

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

ICB

NICE

16. Rimegepant

Drug:

Rimegepant

Indication :

Migraine (prevention)

Status :

Red

Formulations :

Oral lyophilisates

Restrictions / Comments:

Important

For episodic migraine only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

ICB

NICE

17. Clonidine hydrochloride

Drug:

Clonidine hydrochloride

Indication :

Migraine (prevention)

Status :

Non Formulary

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

18. Gabapentin

Drug:

Gabapentin

Indication :

Migraine (prevention)

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1

NICE

19. Pregabalin

Drug:

Pregabalin

Indication :

Migraine (prevention)

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Guidelines SPC

NFD1